Management and nursing strategies for different patterns of adverse events in patients with urological cancer treated with immune checkpoint inhibitors
{{output}}
Background: This study aimed to explore the patterns of treatment-related adverse events (AEs) associated with immune checkpoint inhibitor (ICI) monotherapy and in combination with chemotherapy or tyrosine kinase inhibitor (TKI) ... ...
